MD - MEDNAX, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue3,647,1233,458,3123,183,1592,779,996
Cost of Revenue2,614,7162,415,6522,111,6361,820,385
Gross Profit1,032,4071,042,6601,071,523959,611
Operating Expenses
Research Development----
Selling General and Administrative475,278459,705410,572337,515
Non Recurring----
Others----
Total Operating Expenses3,201,2752,978,2362,611,4722,222,128
Operating Income or Loss445,848480,076571,687557,868
Income from Continuing Operations
Total Other Income/Expenses Net-77,009-69,654-57,888-18,139
Earnings Before Interest and Taxes445,848480,076571,687557,868
Interest Expense-88,769-74,559-63,092-23,110
Income Before Tax368,839410,422513,799539,729
Income Tax Expense100,21090,050189,203204,038
Minority Interest---318
Net Income From Continuing Ops268,629320,372324,596335,691
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income268,629320,372324,914336,320
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares268,629320,372324,914336,320